High risk experimental group
2024-KLS-039-02
Unknown gene_therapy active
Quick answer
High risk experimental group for Adolescent Idiopathic Scoliosis is a Unknown program (gene_therapy) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Adolescent Idiopathic Scoliosis
- Phase
- Unknown
- Modality
- gene_therapy
- Status
- active